A Phase II Single-Arm Open-Labeled Study Evaluating Combination of Quizartinib and Omacetaxine Mepesuccinate (QUIZOM) in Newly Diagnosed or Relapsed/Refractory AML Carrying FlT3-ITD

被引：4

作者：

Zhang, Chunxiao ^{[1
]}

Leung, Garret M. K. ^{[1
]}

Tsui, Sze Pui ^{[2
]}

Ip, Ho-Wan ^{[2
]}

Ma, Edmond S. K. ^{[3
]}

Au, Chun Hang ^{[3
]}

Chan, Chris T. L. ^{[3
]}

Ng, Ka Lam Nelson ^{[1
]}

Yip, Sze Fai ^{[4
]}

Kho, Bonnie ^{[5
]}

Lee, Harold K. K. ^{[6
]}

Liu, Qing ^{[1
]}

Leung, Thomas Wing Yan ^{[1
]}

Kwong, Yok Lam ^{[1
]}

Leung, Anskar Yu Hung ^{[7
]}

机构：

[1] Univ Hong Kong, LKS Fac Med, Div Haematol Med Oncol & Haematopoiet Stem Cell T, Dept Med, Hong Kong, Peoples R China

[2] Queen Mary Hosp, Div Haematol, Dept Pathol, Hong Kong, Peoples R China

[3] Hong Kong Sanat & Hosp, Dept Pathol, Hong Kong, Peoples R China

[4] Tuen Mun Hosp, Tuen Mun, Hong Kong, Peoples R China

[5] Pamela Youde Nethersole Eastern Hosp, Dept Med, Hong Kong, Peoples R China

[6] Princess Margaret Hosp, Dept Med, Hong Kong, Peoples R China

[7] Univ Hong Kong, Dept Med, Hong Kong, Peoples R China

来源：

关键词：

D O I：

10.1182/blood-2019-126510

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3825

引用

页数：3